Skip to main content
. 2013 Jan 31;2013(1):CD000980. doi: 10.1002/14651858.CD000980.pub4
Study Reason for exclusion
Audera 2001c Vitamin C was administered with flavonoids. Thus the comparison was not on vitamin C specifically. There was no difference between placebo and 3 g/day vitamin C + flavonoid groups. 2 other arms are included in our analyses (Audera 2001a; Audera 2001b)
Baird 1979 Low dose. 362 UK students aged 17 to 25 years were studied for 72 days in a double‐blind RCT of regular supplementation. A daily drink contained either synthetic orange juice without ascorbic acid, synthetic juice with 0.08 g/d of ascorbic acid added, or natural orange juice with 0.08 g/d of ascorbic acid added. There was a highly significant reduction in common cold incidence among males (RR 0.63; 95% CI 0.50 to 0.78) but not in females (RR 1.24; 95% CI 0.95 to 1.61) (Hemilä 1997a and Hemilä 2006a). The heterogeneity between sexes was highly significant (Hemilä 2008). The benefit of low‐dose vitamin C supplementation may be explained by low dietary vitamin C intake in the UK (Hemilä 1997a)
Barnes 1961 No placebo comparison. A trial in the USA. A multivitamin preparation that included 0.2 g/d vitamin C was given to 23 members (10 boys, 13 girls) of a basketball team for 7 weeks; medication being received from the coaches. The cold outcomes were compared with those of 16 people (8 boys, 8 girls) of the same age and background. The controls reported to the coaches daily. Days sick from cold were counted in each group. The study took place over 8 weeks during which the basketball players took medication on an average of 43 days. The only usable outcome was "mean days per person" in the vitamin C group 1.48 (SD 2.65) and in the control group 6.87 (SD 8.57). However, there are serious doubts about the comparability of the controls who were apparently not basketball players
Bartley 1953 Low dose. "The volunteers did not know to which group they belonged, nor did the physicians responsible for the clinical investigations. All the volunteers were given each day 7 supplementary tablets of identical taste and appearance, some containing vitamin C, others being dummies" (p 8). 3 participants received 0.07 g/d vitamin C and a total of 14 cold episodes were recorded among them in the follow up, 4 participants were administered 0.01 g/d vitamin C (18 colds), and 6 persons were administered no vitamin C (30 colds). The geometric mean length of colds in vitamin C deprived participants was 6.4 days, and in non‐deprived participants 3.3 days, and the authors concluded "such evidence as there is definitely confirms the hypothesis that the absence of vitamin C tended to cause colds to last longer" (p 43)
Bendel 1955 No placebo comparison and the control group was not parallel. 120 children at a summer camp for 2 weeks were given 0.2 g/d vitamin C daily and their cold experience was compared with that of participants in an earlier camp
Bergquist 1943 Low dose. A Swedish trial involving supplementation with only 0.03 g/d vitamin C
Bessel‐Lorck 1958 No placebo comparison. Berlin school children in a skiing camp. Abridged summary: "26 subjects received 1 g of vitamin C daily during the first 9 days. Under this regimen only one student became sick. In 20 participants the regular supplementation did not begin until the 9th day. At this point in time 9 students were already sick with upper respiratory infections; and 3 others became infected within the first 3 days after the trial began. All of those who were sick were treated with 2 g of vitamin C per day. Within just 24 hours a rapid improvement in the general condition was evident so that elevated physical demands were met without particular difficulty. All participants displayed a significant increase in their capacity to perform physical activities while being treated with vitamin C." The Bessel‐Lorck paper is available as a translation. This trial motivated Ritzel 1961 to carry out his RCT (see Analysis 1.1.2)
Bibile 1966 This was cited by Kleijnen 1989, but we have been unable to retrieve a copy through library orders
Boines 1956 No placebo comparison. Study of poliomyelitis sufferers
Chavance 1993 Low dose. Double‐blind RCT of 0.09 g/d vitamin C in elderly participants. No benefit was demonstrated
Cuendet 1946 No placebo comparison. 200 children in 3 mountain parishes took vitamin C supplements up to 0.3 g/d
Dyllick 1967 No placebo comparison. Cohort workplace study involving 200 recipients of 1 g/d of vitamin C whose respiratory experience was compared with those not receiving vitamin C
Fogelholm 1998 Vitamin C in combination with other antioxidants. Finnish study involving 75 athletes. RCT of 1 g/d vitamin C with 0.3 g/d vitamin E and 0.09 g/d ubiquinone versus an undescribed placebo. Methodologically strong study but was excluded from the meta‐analyses because there were 3 antioxidants in the active preparation which were each hypothesised to be potentially beneficial
Glazebrook 1942 Low dose. 1500 boys at a UK boarding school during World War II. The participants were allocated as administrative units and not on an individual basis. Vitamin C (0.05 to 0.3 g/d) was added to cocoa and milk in the kitchen to a group of 335 boys. Although ineffective powder was not added to the drinks of the control group, the control drinks served functionally as a placebo. The number of participants who had colds was 17% lower in the vitamin C group (72/335 versus 286/1100; P = 0.10, Hemilä 2004) and the number of participants admitted to hospital because of the common cold was 23% lower (59/335 versus 253/1100; P = 0.04, Hemilä 2011)
Gormly 1977 No placebo comparison. 14 males of 29 members of a 1‐year Antarctic expedition took 1 g/d vitamin C throughout their stay. Their health outcomes were compared with the remaining group who did not take vitamin C, and no difference was observed between the 2 groups
Gorton 1999 No placebo comparison and the control group not parallel. A technical training facility in Chile was the site of this cohort study with 250 trainees who were given 3 g/d vitamin C during their 10‐day course. The vitamin C group was compared with a control group of 463 students who had been monitored in a somewhat similar way during the previous year (sic)
Himmelstein 1998b There was an extreme and divergent drop‐out rate in the Himmelstein 1998b trial. They started with 52 marathon runners in 2 groups, but 42% (22 of 52) of the vitamin C group, and 75% (38 of 52) of the placebo group dropped out during the trial (P = 0.003)
Hopfengärtner 1944 Low dose. Long‐term hospital baby study in which supplementation of 0.05 g/d vitamin C was used
Hunt 1994 Not focused on the common cold. Double‐blind RCT. 57 elderly UK patients suffering from acute bronchitis or pneumonia who were admitted to hospital for treatment were administered 0.2 g/d of vitamin C (see Hemilä 2007)
Kimbarowski 1967 No placebo comparison. 216 Russian soldiers were hospitalised because of influenza A. 114 were administered 0.2 g/d vitamin C. There were 2 cases of pneumonia in the vitamin C group in comparison with 10 cases in the control group. Thus this trial found a lower incidence of complications of viral respiratory infection (Hemilä 2004; Hemilä 2007)
Koytchev 2003 No placebo comparison. Double‐blind RCT involving 1167 participants. 4 arms, colds treated with 0.9 g/d vitamin C plus or minus antihistamine and antipyretics
Maggini 2012 Vitamin C in combination with zinc. 1 g/d vitamin C and 10 mg/d zinc for 94 participants. The combination decreased the duration or rhinorrhoea
Masek 1974 Low dose. Two large studies of Czech coal miners comparing 0.1 g/d vitamin C and placebo over a period of 4 or 8 weeks. Excluded both on the basis of low dose and inadequacy of data for inclusion in meta‐analyses. The trials were neither randomised nor blind. Authors claimed benefits to the active recipients
Niemi 1951 Low dose and no placebo comparison. Finnish study with military recruits. 1036 people were observed during a 3‐month period. 516 were administered 0.1 g/d vitamin C. No benefits of vitamin C
Peters 1940 No placebo comparison. Short‐term baby supplementation study
Schmidt 2011 Vitamin C in combination with vitamin D, folic acid and selenium. Double‐blind, placebo‐controlled RCT with 192 patients with recurrent colds. Authors claimed benefits to the active recipients

g/d: grams per day 
 RCT: randomised controlled trial 
 RR: risk ratio 
 SD: standard deviation